Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies ; volume:15 ; number:1 ; day:12 ; month:9 ; year:2018 ; pages:1-11 ; date:12.2018
Retrovirology ; 15, Heft 1 (12.9.2018), 1-11, 12.2018
- Creator
-
Torrents de la Peña, Alba
- Contributor
-
Sanders, Rogier W.
SpringerLink (Online service)
- DOI
-
10.1186/s12977-018-0445-y
- URN
-
urn:nbn:de:101:1-2018102821515432938583
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Torrents de la Peña, Alba
- Sanders, Rogier W.
- SpringerLink (Online service)
Other Objects (12)
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Conformational Changes in the HIV/SIV Envelope Glycoprotein
Glycan shield of the ebolavirus envelope glycoprotein GP
HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
A Functional Henipavirus Envelope Glycoprotein Pseudotyped Lentivirus Assay System
Membrane topology analysis of HIV-1 envelope glycoprotein gp41
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Conformational Changes in the HIV/SIV Envelope Glycoprotein
Glycan shield of the ebolavirus envelope glycoprotein GP
HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
A Functional Henipavirus Envelope Glycoprotein Pseudotyped Lentivirus Assay System
Membrane topology analysis of HIV-1 envelope glycoprotein gp41
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Conformational Changes in the HIV/SIV Envelope Glycoprotein
Glycan shield of the ebolavirus envelope glycoprotein GP
HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
A Functional Henipavirus Envelope Glycoprotein Pseudotyped Lentivirus Assay System